National risk-based control plan for production in the Member States
Article 4
Member States shall prepare a national risk-based control plan for substances in groups A and B of Annex I to Delegated Regulation (EU) 2022/1644 to verify compliance of food-producing animals and products of animal origin produced in the Member States with Union legislation governing the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof and the applicable maximum residue limits (‘MRL’) and maximum levels (‘ML’) in food. The national risk-based control plan for production in the Member States shall contain the following: (a) the list of combinations of substances and species, products and matrices in accordance with Annex II to Delegated Regulation (EU) 2022/1644; (b) the sampling strategy as decided by the Member State in accordance with Annex III to Delegated Regulation (EU) 2022/1644; (c) the actual sampling frequencies as decided by the Member State taking into account the annual minimum control frequencies laid down in Annex I; (d) the analytical methods to be used and their performance characteristics; (e) the detailed information referred to in Article 7(1) and (2). Pursuant to Article 111(2) of Regulation (EU) 2017/625, during the course of the execution of the MANCP, Member States shall review the national risk-based plan for production in the Member States to take account of illegal treatments identified, in particular, through the surveillance plan.